823 related articles for article (PubMed ID: 23841636)
1. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
[TBL] [Abstract][Full Text] [Related]
3. [Foreign body infections--biofilms and quorum sensing].
Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
[TBL] [Abstract][Full Text] [Related]
4. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
5. Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa.
Girard G; Bloemberg GV
Future Microbiol; 2008 Feb; 3(1):97-106. PubMed ID: 18230038
[TBL] [Abstract][Full Text] [Related]
6. The role of bacterial biofilms in chronic infections.
Bjarnsholt T
APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
[TBL] [Abstract][Full Text] [Related]
7. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
[TBL] [Abstract][Full Text] [Related]
8. Terpenoids from Platostoma rotundifolium (Briq.) A. J. Paton Alter the Expression of Quorum Sensing-Related Virulence Factors and the Formation of Biofilm in Pseudomonas aeruginosa PAO1.
Rasamiravaka T; Ngezahayo J; Pottier L; Ribeiro SO; Souard F; Hari L; Stévigny C; Jaziri ME; Duez P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28613253
[No Abstract] [Full Text] [Related]
9. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R
Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
11. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.
Bjarnsholt T; Givskov M
Philos Trans R Soc Lond B Biol Sci; 2007 Jul; 362(1483):1213-22. PubMed ID: 17360273
[TBL] [Abstract][Full Text] [Related]
12. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?
Kirisits MJ; Parsek MR
Cell Microbiol; 2006 Dec; 8(12):1841-9. PubMed ID: 17026480
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability-enhanced Resveramax™ modulates quorum sensing and inhibits biofilm formation in Pseudomonas aeruginosa PAO1.
Vasavi HS; Sudeep HV; Lingaraju HB; Shyam Prasad K
Microb Pathog; 2017 Mar; 104():64-71. PubMed ID: 28065820
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.
Fothergill JL; Winstanley C; James CE
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):219-35. PubMed ID: 22339195
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa biofilms: mechanisms of immune evasion.
Alhede M; Bjarnsholt T; Givskov M; Alhede M
Adv Appl Microbiol; 2014; 86():1-40. PubMed ID: 24377853
[TBL] [Abstract][Full Text] [Related]
18. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
[TBL] [Abstract][Full Text] [Related]
19. Zingerone silences quorum sensing and attenuates virulence of Pseudomonas aeruginosa.
Kumar L; Chhibber S; Kumar R; Kumar M; Harjai K
Fitoterapia; 2015 Apr; 102():84-95. PubMed ID: 25704369
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of new antibacterial drugs that target bacterial quorum sensing systems].
Yin SL; Chang YJ; Deng SP; Wang QC; Yu WG; Gong QH
Yao Xue Xue Bao; 2011 Jun; 46(6):613-21. PubMed ID: 21882519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
